ORION CORPORATION STOCK EXCHANGE RELEASE 19 JULY 2016 at 11:00 a.m. EEST
Orion Corporation's publication schedules for financial reporting in 2017
Orion Corporation will publish its Financial Statement Release 2016 on Wednesday, 8 February 2017.
The publication dates of the Interim Reports and the Half-Yearly Report in 2017 are as follows:
Interim Report January-March 2017 Wednesday, 26 April 2017
Half-Yearly Report January-June 2017 Wednesday, 19 July 2017
Interim Report January-September 2017 Thursday, 26 October 2017
The Financial Statements and the report of the Board of Directors 2016 will be published on the Company's website at the latest in week 9/2017.
The Annual General Meeting is planned to be held on Wednesday, 22 March 2017 in Helsinki.
Orion's financial reports and related presentation material are available on the Group's website at http://www.orion.fi/investors promptly after the publishing. The website also provides a possibility to register on Orion's mailing lists for releases.
| Timo Lappalainen|
President and CEO
| Olli Huotari|
SVP, Corporate Functions
Tuukka Hirvonen, Communications Manager, financial communications and investor relations
tel. +358 10 426 2721
Orionintie 1A, FI-02101 Espoo, Finland
Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory for which Orion developes inhaled Easyhaler® pulmonary drugs.
Orion's net sales in 2015 amounted to EUR 1,016 million and the company had about 3,400 employees. Orion's A and B shares are listed on Nasdaq Helsinki..